| Methods for treating coronavirus infection and resulting inflammation-induced … |
2022-8-31 |
2022-11-01 |
|
| Methods of treating immunotherapy-related toxicity using a gm-csf antagonist |
2022-4-19 |
2023-3-01 |
|
| Materials and methods for treating cancer |
2022-3-15 |
2022-9-29 |
|
| Methods for treating coronavirus infection and resulting inflammation-induced … |
2022-3-08 |
2022-12-01 |
|
| Methods of treating immunotherapy-related toxicity using a gm-csf antagonist |
2021-7-16 |
2022-1-27 |
|
| Methods for treating coronavirus infection and resulting inflammation-induced … |
2021-5-03 |
2022-11-17 |
|
| Methods of treating immunotherapy-related toxicity using a gm-csf antagonist |
2021-4-19 |
2021-10-21 |
|
| Methods for treating coronavirus infection and resulting inflammation-induced … |
2021-3-08 |
2023-4-06 |
|
| Methods of treating immunotherapy-related toxicity using a gm-csf antagonist |
2021-3-03 |
2021-4-29 |
|
| Methods of treating immunotherapy-related toxicity using a gm-csf antagonist |
2021-1-27 |
2021-7-29 |
|
| Methods of treating immunotherapy-related toxicity using a gm-csf antagonist |
2021-1-16 |
2021-9-02 |
|
| Methods of treating immunotherapy-related toxicity using a gm-csf antagonist |
2020-11-13 |
2021-5-06 |
|
| Epha3 directed car-t cells for treatment of tumors |
2020-11-09 |
2021-9-16 |
|
| Methods of treating immunotherapy-related toxicity using a gm-csf antagonist |
2019-9-10 |
2021-9-23 |
|
| Epha3 antibodies for the treatment of pulmonary fibrosis |
2017-9-13 |
2019-7-24 |
|
| Detection of epha3 as marker of presence of solid tumor |
2016-10-14 |
2017-3-09 |
|
| Treatment of Leukemias and Chronic Myeloproliferative Diseases with Antibodies … |
2016-9-14 |
2017-8-10 |
|
| Immunoglobulin variable region cassette exchange |
2015-12-14 |
2021-2-16 |
2021-2-16 |
| Antibodies to epha3 |
2015-11-25 |
2016-5-26 |
|
| Methods of Treating Hematological Proliferative Disorders by Targeting EphA3 … |
2015-7-30 |
2015-11-19 |
|
| Methods of treating chronic inflammatory diseases using a gm-csf antagonist |
2015-5-14 |
2015-9-03 |
|
| Antibodies to granulocyte-macrophage colony-stimulating factor |
2015-4-02 |
2015-12-03 |
|
| Antibodies to the pcrv antigen of pseudomonas aeruginosa |
2014-10-08 |
2015-1-29 |
|
| Methods of treating dementia using a gm-csf antagonist |
2013-2-22 |
2013-6-20 |
|
| Generation of antibodies to an epitope of interest that contains a … |
2012-10-04 |
2013-5-02 |
|
| Anti-emr1 antibodies |
2012-5-25 |
2015-4-22 |
|
| Secretion of antibodies without signal peptides from bacteria |
2012-5-07 |
2015-9-08 |
2015-9-08 |
| Methods of treating chronic inflammatory diseases using a GM-CSF antagonist |
2012-4-18 |
2012-5-10 |
|
| Methods of treating bone-loss disorders using a gm-csf antagonist |
2011-7-08 |
2012-1-12 |
|
| Generation of antibodies to an epitope of interest |
2011-4-04 |
2013-2-06 |
|
| EphA3 antibodies for the treatment of multiple myeloma |
2011-4-01 |
2012-10-25 |
|
| A method of treating a staphylococcus infection in a patient having a low-level … |
2010-12-21 |
2011-7-21 |
|
| Combination antibiotic and antibody therapy for the treatment of pseudomonas … |
2010-2-04 |
2010-8-12 |
|
| Neutralization of gm-csf for the treatment of heart failure |
2009-4-07 |
2011-2-16 |
|
| Anti-trkb antibodies |
2009-1-16 |
2011-4-28 |
|
| Antibodies against EphA3 for the treatment of solid tumors |
2008-3-10 |
2022-5-12 |
2022-5-12 |
| Methods of treating idiopathic thrombocytopenia purpura using a gm-csf … |
2007-11-08 |
2008-7-17 |
|
| Antibody specificity transfer using minimal essential binding determinants |
2005-1-20 |
2009-10-21 |
|
| Transactivation system for mammalian cells |
2004-12-30 |
2006-9-20 |
|
| Antibody affinity engineering by serial epitope-guided complementarity … |
2004-2-13 |
2005-1-13 |
|
| Methods for affinity maturation |
2003-9-30 |
2004-7-08 |
|
| Detection of molecular interaction by reactivation of an auto-inhibited … |
2003-2-14 |
2005-9-07 |
|
| Molecular sensors by competitive activation |
2003-2-14 |
2003-9-04 |
|
| Reactivation-based molecular interaction sensors |
2002-7-29 |
2008-2-26 |
2008-2-26 |
| Affinity maturation by competitive selection |
2001-10-30 |
2002-10-24 |
|
| Circularly permutated, interaction-activated proteins |
2001-1-16 |
2001-7-19 |
|